Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Fuss Brands Corp. (FBDS : OTC)
 
 • Company Description   
FUSS BRANDS INC. engages in the research, manufacture and distribution of botanical products, bio-pharmaceutical products and traditional Chinese medicines. Its products include Siberian ginseng, other plant-based anti-depression and nerve regulation products, botanical antibiotics, badger oil and ginseng and deer antler extracts. FUSS BRANDS INC., formerly known as China Botanic Pharmaceutical Inc., is based in New York.

Number of Employees: 1

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.06 Daily Weekly Monthly
20 Day Moving Average: 1 shares
Shares Outstanding: 21.45 (millions)
Market Capitalization: $1.22 (millions)
Beta: -2.54
52 Week High: $0.55
52 Week Low: $0.01
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.00% 1.52%
12 Week -15.37% -18.26%
Year To Date 1.25% 1.39%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
80 BROAD STREET 5TH FLOOR
-
NEW YORK,NY 10036
USA
ph: 917-720-3366
fax: 86-451-5760-4764
ir@renhuang.com http://www.fussbrands.com
 
 • General Corporate Information   
Officers
Cheskel Meisels - Chief Executive Officer; Treasurer; and Secretary
Weiqiu Dong - Chief Financial Officer
Zack Pan - Director
Bingchun Wu - Director
Changxiong Sun - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 16890Y203
SIC: 2834
Fiscal Year
Fiscal Year End: October
Last Reported Quarter: 07/01/25
Next Expected EPS Date: 03/04/26
Share - Related Items
Shares Outstanding: 21.45
Most Recent Split Date: 7.00 (0.04:1)
Beta: -2.54
Market Capitalization: $1.22 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 03/04/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
01/31/26 - -
10/31/25 - -
07/31/25 - -
ROA
01/31/26 - -
10/31/25 - -
07/31/25 - -64.36
Current Ratio
01/31/26 - -
10/31/25 - -
07/31/25 - 0.22
Quick Ratio
01/31/26 - -
10/31/25 - -
07/31/25 - 0.22
Operating Margin
01/31/26 - -
10/31/25 - -
07/31/25 - -
Net Margin
01/31/26 - -
10/31/25 - -
07/31/25 - -
Pre-Tax Margin
01/31/26 - -
10/31/25 - -
07/31/25 - -
Book Value
01/31/26 - -
10/31/25 - -
07/31/25 - -0.04
Inventory Turnover
01/31/26 - -
10/31/25 - -
07/31/25 - -
Debt-to-Equity
01/31/26 - -
10/31/25 - -
07/31/25 - -
Debt-to-Capital
01/31/26 - -
10/31/25 - -
07/31/25 - -
 

Powered by Zacks Investment Research ©